Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2532990rdf:typepubmed:Citationlld:pubmed
pubmed-article:2532990lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:2532990lifeskim:mentionsumls-concept:C0024141lld:lifeskim
pubmed-article:2532990lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:2532990lifeskim:mentionsumls-concept:C1155003lld:lifeskim
pubmed-article:2532990lifeskim:mentionsumls-concept:C0020846lld:lifeskim
pubmed-article:2532990lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:2532990lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:2532990lifeskim:mentionsumls-concept:C1414549lld:lifeskim
pubmed-article:2532990lifeskim:mentionsumls-concept:C0205100lld:lifeskim
pubmed-article:2532990lifeskim:mentionsumls-concept:C1521805lld:lifeskim
pubmed-article:2532990lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:2532990lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:2532990lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:2532990pubmed:issue3lld:pubmed
pubmed-article:2532990pubmed:dateCreated1990-2-27lld:pubmed
pubmed-article:2532990pubmed:abstractTextTo clarify the differential state of B cell activation in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), we investigated the expression of low-affinity receptor for IgE (Fc epsilon RII; CD23) on their peripheral B cells by a cytofluorometry using H107 (CD23) and Leu-16 (CD20) monoclonal antibodies. The percentage of CD23-negative B cells in total lymphocytes was significantly greater in both groups of patients than in normal subjects, suggesting the hyperactivity of late-phase B cells in both diseases. However, the increase of CD23-negative B cells in RA was brought about by the increased number of total B cells, although that in SLE was mainly based on the relative decrease of CD23-positive B cells. The number of IgD-positive B cells was decreased, and the number of colony-forming B cells was markedly increased in SLE patients. These observations indicate that a B cell abnormality is mainly qualitative in SLE but quantitative in RA.lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:languageenglld:pubmed
pubmed-article:2532990pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:citationSubsetIMlld:pubmed
pubmed-article:2532990pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2532990pubmed:statusMEDLINElld:pubmed
pubmed-article:2532990pubmed:monthDeclld:pubmed
pubmed-article:2532990pubmed:issn0009-9104lld:pubmed
pubmed-article:2532990pubmed:authorpubmed-author:IshidaHHlld:pubmed
pubmed-article:2532990pubmed:authorpubmed-author:ArayaSSlld:pubmed
pubmed-article:2532990pubmed:authorpubmed-author:IwaiKKlld:pubmed
pubmed-article:2532990pubmed:authorpubmed-author:ImuraHHlld:pubmed
pubmed-article:2532990pubmed:authorpubmed-author:OzakiSSlld:pubmed
pubmed-article:2532990pubmed:authorpubmed-author:KumagaiSSlld:pubmed
pubmed-article:2532990pubmed:authorpubmed-author:TsubataTTlld:pubmed
pubmed-article:2532990pubmed:authorpubmed-author:UmeharaHHlld:pubmed
pubmed-article:2532990pubmed:authorpubmed-author:SuginoshitaTTlld:pubmed
pubmed-article:2532990pubmed:issnTypePrintlld:pubmed
pubmed-article:2532990pubmed:volume78lld:pubmed
pubmed-article:2532990pubmed:ownerNLMlld:pubmed
pubmed-article:2532990pubmed:authorsCompleteYlld:pubmed
pubmed-article:2532990pubmed:pagination348-53lld:pubmed
pubmed-article:2532990pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2532990pubmed:meshHeadingpubmed-meshheading:2532990-...lld:pubmed
pubmed-article:2532990pubmed:meshHeadingpubmed-meshheading:2532990-...lld:pubmed
pubmed-article:2532990pubmed:meshHeadingpubmed-meshheading:2532990-...lld:pubmed
pubmed-article:2532990pubmed:meshHeadingpubmed-meshheading:2532990-...lld:pubmed
pubmed-article:2532990pubmed:meshHeadingpubmed-meshheading:2532990-...lld:pubmed
pubmed-article:2532990pubmed:meshHeadingpubmed-meshheading:2532990-...lld:pubmed
pubmed-article:2532990pubmed:meshHeadingpubmed-meshheading:2532990-...lld:pubmed
pubmed-article:2532990pubmed:meshHeadingpubmed-meshheading:2532990-...lld:pubmed
pubmed-article:2532990pubmed:meshHeadingpubmed-meshheading:2532990-...lld:pubmed
pubmed-article:2532990pubmed:meshHeadingpubmed-meshheading:2532990-...lld:pubmed
pubmed-article:2532990pubmed:meshHeadingpubmed-meshheading:2532990-...lld:pubmed
pubmed-article:2532990pubmed:year1989lld:pubmed
pubmed-article:2532990pubmed:articleTitlePossible different mechanisms of B cell activation in systemic lupus erythematosus and rheumatoid arthritis: opposite expression of low-affinity receptors for IgE (CD23) on their peripheral B cells.lld:pubmed
pubmed-article:2532990pubmed:affiliationSecond Division of Internal Medicine, Kyoto University Medical School, Japan.lld:pubmed
pubmed-article:2532990pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2532990pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2532990lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2532990lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2532990lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2532990lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2532990lld:pubmed